The case for testing Pfizer's Paxlovid for treating long COVID - Reuters

Reports of two patients who found relief from long COVID after taking Pfizer Inc's <a href="https://www.reuters.com/companies/PFE.N" target="_blank">(PFE.N)</a> antiviral Paxlovid, including a researcher who tested it on herself, provide intriguing evidence f…

CHICAGO, April 18 (Reuters) - Reports of two patients who found relief from long COVID after taking Pfizer Inc's (PFE.N) antiviral Paxlovid, including a researcher who tested it on herself, provide i… [+5284 chars]

full article...